DiaMedica Therapeutics

DMAC

Capitalización de mercado USD 454 M

#	Nombre	Posición	Valor operado	Cambio en acciones	Cambio en la participación
1	1 Wexford Capital West Palm Beach, Florida	USD 1.98 M	-USD 259 k	-75,000	-16%
2	MHP 2 Manatuck Hill Partners Westport, Connecticut	USD 1.33 M	+USD 400 k	+115,800	+76%
3	3 Granite Point Capital Management Boston, Massachusetts	USD 1.14 M	+USD 795 k	+229,970	Nuevas
4	4 Worth Venture Partners Fort Lee, New Jersey	USD 657 k	+USD 43.7 k	+12,651	+11%
5	5 Millennium Management New York	USD 493 k	+USD 344 k	+99,340	Nuevas
6	6 Goldman Sachs New York	USD 253 k	+USD 177 k	+51,061	Nuevas
7	7 Eidelman Virant Capital Saint Louis, Missouri	USD 173 k	+USD 121 k	+35,000	Nuevas
8	8 Vanguard Group Malvern, Pennsylvania	USD 170 k	+USD 118 k	+34,238	Nuevas
9	9 BlackRock New York	USD 134 k	+USD 57.6 k	+16,651	+160%
10	10 UBS Group Zurich, Switzerland	USD 11 k	+USD 7.78 k	+2,250	Nuevas
11	11 Patriot Financial Group Insurance Agency Westborough, Massachusetts	USD 10 k	-USD 3.46 k	-1,000	-33%
12	12 Royal Bank of Canada Toronto, Ontario, Canada	USD 10 k	–	–	–
13	13 Bank of Montreal Toronto, Ontario, Canada	USD 2 k	–	–	–
14	14 FNY Investment Advisers New York	USD 2 k	+USD 1.8 k	+521	Nuevas
15	15 Gables Capital Management Miami, Florida	USD 1 k	–	–	–
16	16 Stonepine Capital Management Bend, Oregon	–	-USD 1.14 M	-250,000	Cerradas
17	17 Cable Hill Partners Portland, Oregon	–	-USD 5 k	-1,000	Cerradas
18	18 Toronto Dominion Bank Toronto, Ontario, Ontario, Canada	–	+USD 83	+24	Nuevas